Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Thomas Greß"'
Autor:
Hanna Elisabeth Schneider, Lisa-Maria Schmitt, Albert Job, Brigitte Lankat-Buttgereit, Thomas Gress, Malte Buchholz, Eike Gallmeier
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 57, Iss , Pp 101038- (2024)
The ATR-CHK1 pathway plays a fundamental role in the DNA damage response and is therefore an attractive target in cancer therapy. The antitumorous effect of ATR inhibitors is at least partly caused by synthetic lethality between ATR and various DNA r
Externí odkaz:
https://doaj.org/article/d9d2994e1d8b40feb85caf545e7e1dad
Autor:
Sebastian Foersch, Maxime Schmitt, Anne‐Sophie Litmeyer, Markus Tschurtschenthaler, Thomas Gress, Detlef K Bartsch, Nicole Pfarr, Katja Steiger, Carsten Denkert, Moritz Jesinghaus
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 5, Pp n/a-n/a (2024)
Abstract Antibody–drug conjugates (ADCs) directed to trophoblast cell surface antigen 2 (TROP2) have gained approval as a therapeutic option for advanced triple‐negative breast cancer, and TROP2 expression has been linked to unfavourable outcomes
Externí odkaz:
https://doaj.org/article/8a36804c34c64ace9a0a2bc6238a569b
Publikováno v:
Results in Materials, Vol 20, Iss , Pp 100471- (2023)
The formation mechanisms of intermetallic layers and the development of the interface between solid brass and molten Al alloy were experimentally investigated using semi-infinite solid-liquid diffusion couples. Isothermal annealing of commercial CuZn
Externí odkaz:
https://doaj.org/article/eaf177ce49174ea6bd24f16d5f79f984
Autor:
Xu Zhou, Kai Hu, Peter Bailey, Christoph Springfeld, Susanne Roth, Roma Kurilov, Benedikt Brors, Thomas Gress, Malte Buchholz, Jingyu An, Kongyuan Wei, Teresa Peccerella, Markus W. Büchler, Thilo Hackert, John P. Neoptolemos
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Externí odkaz:
https://doaj.org/article/eeec39dc7627400fb88ad3927107e6fd
Autor:
Evangelina López de Maturana, Juan Antonio Rodríguez, Lola Alonso, Oscar Lao, Esther Molina-Montes, Isabel Adoración Martín-Antoniano, Paulina Gómez-Rubio, Rita Lawlor, Alfredo Carrato, Manuel Hidalgo, Mar Iglesias, Xavier Molero, Matthias Löhr, Christopher Michalski, José Perea, Michael O’Rorke, Victor Manuel Barberà, Adonina Tardón, Antoni Farré, Luís Muñoz-Bellvís, Tanja Crnogorac-Jurcevic, Enrique Domínguez-Muñoz, Thomas Gress, William Greenhalf, Linda Sharp, Luís Arnes, Lluís Cecchini, Joaquim Balsells, Eithne Costello, Lucas Ilzarbe, Jörg Kleeff, Bo Kong, Mirari Márquez, Josefina Mora, Damian O’Driscoll, Aldo Scarpa, Weimin Ye, Jingru Yu, PanGenEU Investigators, Montserrat García-Closas, Manolis Kogevinas, Nathaniel Rothman, Debra T Silverman, SBC/EPICURO Investigators, Demetrius Albanes, Alan A Arslan, Laura Beane-Freeman, Paige M Bracci, Paul Brennan, Bas Bueno-de-Mesquita, Julie Buring, Federico Canzian, Margaret Du, Steve Gallinger, J Michael Gaziano, Phyllis J Goodman, Marc Gunter, Loic LeMarchand, Donghui Li, Rachael E Neale, Ulrika Peters, Gloria M Petersen, Harvey A Risch, Maria José Sánchez, Xiao-Ou Shu, Mark D Thornquist, Kala Visvanathan, Wei Zheng, Stephen J Chanock, Douglas Easton, Brian M Wolpin, Rachael Z Stolzenberg-Solomon, Alison P Klein, Laufey T Amundadottir, Marc A Marti-Renom, Francisco X Real, Núria Malats
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-18 (2021)
Abstract Background Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic var
Externí odkaz:
https://doaj.org/article/fd82873a71df49c79bdc3dadb14c043b
Autor:
Xu Zhou, Kai Hu, Peter Bailey, Christoph Springfeld, Susanne Roth, Roma Kurilov, Benedikt Brors, Thomas Gress, Malte Buchholz, Jingyu An, Kongyuan Wei, Teresa Peccerella, Markus W. Büchler, Thilo Hackert, John P. Neoptolemos
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Pancreatic ductal adenocarcinoma is a highly lethal malignancy, which has now become the seventh most common cause of cancer death in the world, with the highest mortality rates in Europe and North America. In the past 30 years, there has been some p
Externí odkaz:
https://doaj.org/article/6ac554b584fe45208d4983a549229ada
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/6c74972ac6a04e26bc4722df4611531a
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d4c5758fbc814ec38b11550f56e4c4d4
Autor:
Christian Keller, Malte Zumblick, Katrin Streubel, Markus Eickmann, Daniela Müller, Martina Kerwat, Stephan Becker, Thomas Gress
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 5, Pp 917-919 (2016)
Externí odkaz:
https://doaj.org/article/e8855230456c4923a7ca91052e601458
Autor:
Nada Milosevic, Benjamin Kühnemuth, Leonie Mühlberg, Stefanie Ripka, Heidi Griesmann, Carolin Lölkes, Malte Buchholz, Daniela Aust, Christian Pilarsky, Sebastian Krug, Thomas Gress, Patrick Michl
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 12, Pp 1354-1362 (2013)
Pancreatic cancer is characterized by a high degree of resistance to chemotherapy. Epidermal growth factor receptor (EGFR) inhibition using the small-molecule inhibitor erlotinib was shown to provide a small survival benefit in a subgroup of patients
Externí odkaz:
https://doaj.org/article/83e23b3388324c8393c98fa1bcd9721d